Keyphrases
Paclitaxel
100%
Human Embryonic Stem Cells (hESCs)
100%
Genetic Screening
100%
Tumor Resistance
100%
Carboplatin
100%
Anticancer Drugs
33%
Cancer Types
16%
Tumor
16%
Cell Death
16%
Mutation Effect
16%
Survival Rate
16%
Prediction Tool
16%
Loss-of-function Screen
16%
Unmet Needs
16%
Cancer Cell Proliferation
16%
Patient's Will
16%
Early Prediction
16%
Gene Pathway
16%
Patient Tumor
16%
Poor Survival
16%
Treatment Survival
16%
Gene Lists
16%
DNA mutation
16%
Innate Resistance
16%
Resistance Prediction
16%
Mutation Profiling
16%
Paclitaxel Resistance
16%
Taxanes
16%
Carboplatin Resistance
16%
First-line Chemotherapy
16%
Medicine and Dentistry
Human Embryonic Stem Cell
100%
Paclitaxel
100%
Tumor Resistance
100%
Carboplatin
100%
Anticancer Drug
28%
Tumor
28%
Cancer Types
14%
Cancer Cell
14%
Cell Proliferation
14%
Survival Rate
14%
Cell Death
14%
Genetic Screening
14%
DNA Mutation
14%
First-Line Chemotherapy
14%
Pharmacology, Toxicology and Pharmaceutical Science
Paclitaxel
100%
Tumor Resistance
100%
Carboplatin
100%
Malignant Neoplasm
28%
Anticancer Drug
28%
Survival Rate
14%
Taxane
14%
First-Line Chemotherapy
14%
Biochemistry, Genetics and Molecular Biology
Embryonic Stem Cell
100%
Anticancer
66%
Cancer Cell
33%
Cell Proliferation
33%
Genetic Screening
33%
Cell Death
33%
Survival Rate
33%
DNA Mutation
33%